BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22307680)

  • 1. The amyloid-β isoform pattern in cerebrospinal fluid in familial PSEN1 M139T- and L286P-associated Alzheimer's disease.
    Portelius E; Fortea J; Molinuevo JL; Gustavsson MK; Andreasson U; Sanchez-Valle R
    Mol Med Rep; 2012 Apr; 5(4):1111-5. PubMed ID: 22307680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease.
    Portelius E; Andreasson U; Ringman JM; Buerger K; Daborg J; Buchhave P; Hansson O; Harmsen A; Gustavsson MK; Hanse E; Galasko D; Hampel H; Blennow K; Zetterberg H
    Mol Neurodegener; 2010 Jan; 5():2. PubMed ID: 20145736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease.
    Portelius E; Zhang B; Gustavsson MK; Brinkmalm G; Westman-Brinkmalm A; Zetterberg H; Lee VM; Trojanowski JQ; Blennow K
    Neurodegener Dis; 2009; 6(5-6):258-62. PubMed ID: 19955704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells.
    Wiltfang J; Esselmann H; Cupers P; Neumann M; Kretzschmar H; Beyermann M; Schleuder D; Jahn H; Rüther E; Kornhuber J; Annaert W; De Strooper B; Saftig P
    J Biol Chem; 2001 Nov; 276(46):42645-57. PubMed ID: 11526104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of familial Alzheimer's disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity.
    Schilling S; Pradhan A; Heesch A; Helbig A; Blennow K; Koch C; Bertgen L; Koo EH; Brinkmalm G; Zetterberg H; Kins S; Eggert S
    Acta Neuropathol Commun; 2023 Jun; 11(1):87. PubMed ID: 37259128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knock-in rats with homozygous
    Tambini MD; D'Adamio L
    J Biol Chem; 2020 May; 295(21):7442-7451. PubMed ID: 32265300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer's disease.
    Serneels L; T'Syen D; Perez-Benito L; Theys T; Holt MG; De Strooper B
    Mol Neurodegener; 2020 Oct; 15(1):60. PubMed ID: 33076948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. γ-secretase binding sites in aged and Alzheimer's disease human cerebrum: the choroid plexus as a putative origin of CSF Aβ.
    Liu F; Xue ZQ; Deng SH; Kun X; Luo XG; Patrylo PR; Rose GM; Cai H; Struble RG; Cai Y; Yan XX
    Eur J Neurosci; 2013 May; 37(10):1714-25. PubMed ID: 23432732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.
    Portelius E; Brinkmalm G; Tran AJ; Zetterberg H; Westman-Brinkmalm A; Blennow K
    Neurodegener Dis; 2009; 6(3):87-94. PubMed ID: 19229112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease.
    Jayne T; Newman M; Verdile G; Sutherland G; Münch G; Musgrave I; Moussavi Nik SH; Lardelli M
    J Alzheimers Dis; 2016 Apr; 52(3):781-99. PubMed ID: 27060961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques.
    Miravalle L; Calero M; Takao M; Roher AE; Ghetti B; Vidal R
    Biochemistry; 2005 Aug; 44(32):10810-21. PubMed ID: 16086583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Alzheimer's disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta.
    Arber C; Toombs J; Lovejoy C; Ryan NS; Paterson RW; Willumsen N; Gkanatsiou E; Portelius E; Blennow K; Heslegrave A; Schott JM; Hardy J; Lashley T; Fox NC; Zetterberg H; Wray S
    Mol Psychiatry; 2020 Nov; 25(11):2919-2931. PubMed ID: 30980041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aβ43 levels determine the onset of pathological amyloid deposition.
    Tambini MD; Yin T; Yesiltepe M; Breuillaud L; Zehntner SP; d'Abramo C; Giliberto L; D'Adamio L
    J Biol Chem; 2023 Jul; 299(7):104868. PubMed ID: 37257821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. γ-Secretase processing and effects of γ-secretase inhibitors and modulators on long Aβ peptides in cells.
    Ran Y; Cruz PE; Ladd TB; Fauq AH; Jung JI; Matthews J; Felsenstein KM; Golde TE
    J Biol Chem; 2014 Feb; 289(6):3276-87. PubMed ID: 24352661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the performance of novel Aβ isoforms as theragnostic markers in Alzheimer's disease: from the cell to the patient.
    Portelius E; Gustavsson MK; Zetterberg H; Andreasson U; Blennow K
    Neurodegener Dis; 2012; 10(1-4):138-40. PubMed ID: 22302034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aβ profiles generated by Alzheimer's disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset.
    Petit D; Fernández SG; Zoltowska KM; Enzlein T; Ryan NS; O'Connor A; Szaruga M; Hill E; Vandenberghe R; Fox NC; Chávez-Gutiérrez L
    Mol Psychiatry; 2022 Jun; 27(6):2821-2832. PubMed ID: 35365805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease.
    Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G
    Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-β
    Perrone F; Bjerke M; Hens E; Sieben A; Timmers M; De Roeck A; Vandenberghe R; Sleegers K; Martin JJ; De Deyn PP; Engelborghs S; van der Zee J; Van Broeckhoven C; Cacace R;
    Alzheimers Res Ther; 2020 Sep; 12(1):108. PubMed ID: 32917274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
    Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O
    Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.